The skeletal muscle VEGF mRNA response to acute exercise in patients with chronic heart failure

Growth Factors

Volumn 28, Issue 2, 2010, Pages 139-147

  Esposito, Fabio ^a,b   Mathieu Costello, Odile ^b   Entin, Pauline L ^b   Wagner, Peter D ^b   Richardson, Russell S ^b,c,d,e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute exercise; CHF; Morphology; Muscle; VEGF

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; NITRIC ACID DERIVATIVE; VASCULOTROPIN; WARFARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; HEART FAILURE; HUMAN; HUMAN TISSUE; LEG EXERCISE; MALE; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE BLOOD FLOW; MUSCLE FUNCTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REST; SKELETAL MUSCLE; SURFACE PROPERTY; UPREGULATION; VASCULAR RESISTANCE;

CHRONIC DISEASE; EXERCISE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949432925     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903512602     Document Type: Article

References (40)

1. Abraham D, Hofbauer R, Schafer R, Blumer R, Paulus P, Miksovsky A, Traxler H, Kocher A, Aharinejad S. 2000. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 87:644-647.
2. Arakawa H, Ikeda U, Hojo Y, Ueno S, Nonaka-Sarukawa M, Yamamoto K, Shimada K. 2003. Decreased serum vascular endothelial growth factor concentrations in patients with congestive heart failure. Heart 89:207-208.
3. Bergstrom J. 1975. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616.
4. Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GY. 2002. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 90:1258-1260.
5. De Boer RA, Henning RH, Tio RA, Pinto YM, Brouwer RM, Ploeg RJ, Bohm M, Van Gilst WH, Van Veldhuisen DJ. 2002. Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy. Heart 88:412-414.
6. Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751-1759.
7. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH, Pippen AM, Brawner CA, Blank JM, Annex BH. 1999. Capillary density of skeletal muscle: A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 33:1956-1956
8. Egginton S, Hudlicka O, Brown MD, Walter H, Weiss JB, Bate A. 1998. Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl Physiol 85:2025-2032.
9. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
10. Fong GH, Rossant J, Gertsenstein M, Breitman ML. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
11. Gustafsson T, Bodin K, Sylven C, Gordon A, Tyni-Lenne R, Jansson E. 2001. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest 31:362-366.
12. Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ. 1999. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 276:H679-H685.
13. Harrington D, Anker SD, Chua TP,Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, Coats AJ. 1997. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30:1758-1764.
14. Hepple RT, Hogan MC, Stary C, Bebout DE, Mathieu-Costello O, Wagner PD. 2000. Structural basis of muscle O(2) diffusing capacity: Evidence from muscle function in situ. J Appl Physiol 88:560-566.
15. Hogan MC, Roca J, West JB, Wagner PD. 1989. Dissociation of maximal O2 uptake from O2 delivery in canine gastrocnemius in situ. J Appl Physiol 66:1219-1226.
16. Hudlicka O. 1998. Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5:5-23.
17. Kennedy B, Ziegler MG. 1990. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 47: 2143-2153.
18. Kraus WE, Deuscha BD, Thompson MA, Pippen AM, Keteyian SJ, Sullivan MJ. 1999. Vascular endothelial growth factor level in skeletal muscle are reduced in patients with congestive heart failure (abstract). Circulation 100:246.
19. LeJemtel TH, Maskin CS, LucidoD, Chadwick BJ. 1986. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74:245-251.
20. LeungDW, Cachianes G, Kuang WJ, GoeddelDV, FerraraN. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
21. Magnusson G, Kaijser L, Sylvén C, Karlberg KE, Isberg B, Saltin B. 1997. Peak skeletal muscle perfusion is maintained in patients with chronic heart failure when only a small muscle mass is exercised. Cardiovasc Res 33:297-306.
22. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. 1992. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364-1373.
23. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. 1996. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27:140-145.
24. Mathieu-Costello O. 1987. Capillary tortuosity and degree of contraction or extension of skeletal muscles. Microvasc Res 33:98-117.
25. Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL, Wagner PD, Breen EC. 2009. Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587: 1755-1767.
26. Richardson RS, Knight DR, Poole DC, Kurdak SS, Hogan MC, Grassi B, Wagner PD. 1995. Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am J Physiol 268:H1453-H1461.
27. Richardson RS, Poole DC, Knight DR, Kurdak SS, Hogan MC, Grassi B, Johnson EC, Kendrick KF, Erickson BK, Wagner PD. 1916. 1993. High muscle blood flow in man: Is maximal O2 extraction compromised? J Appl Physiol 75:1911-1911
28. Richardson RS, Poole DC, Knight DR, Wagner PD. 1994. Red blood cell transit time in man: Theoretical effects of capillary density. Adv Exp Med Biol 361:521-532.
29. Richardson RS,Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD. 1999. Human VEGF gene expression in skeletal muscle: Effect of acute normoxic and hypoxic exercise. Am J Physiol 277:H2247-H2252.
30. Richardson RS, Wagner H, Mudaliar SR, Saucedo E, Henry R, Wagner PD. 2000. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol 279:H772-H778.
31. Rosenblatt JD, Kuzon WM, Jr, Plyley MJ, Pynn BR, McKee NH. 1987. A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol 62:85-92.
32. Savard GK, Richter EA, Strange S, Kiens B, Christensen NJ, Saltin B. 1989. NE spillover from skeletal muscle during exercise in humans: Role of muscle mass. Am J Physiol 257: H1812-H1818.
33. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
34. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. 1989. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure: Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 80:769-781.
35. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD. 2004. Capillary regression in vascular endothelial growth factordeficient skeletal muscle. Physiol Genomics 18:63-69.
36. Testa M, Ennezat PV, Vikstrom KL, Demopoulos L, Gentilucci M, Loperfido F, Fanelli R, Kitsis RN, Leinwand LA, LeJemtel TH. 2000. Modulation of vascular endothelial gene expression by physical training in patients with chronic heart failure. Ital Heart J 1:426-430.
37. Weibel E. 1979. Practical methods for biological morphometry. New York: Academic Press.
38. Wilting J, Christ B, Bokeloh M, Weich HA. 1993. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 274:163-172.
39. Zachar V, Thomas RA, Goustin AS. 1993. Absolute quantification of target DNA: A simple competitive PCR for efficient analysis of multiple samples. Nucleic Acids Res 21:2017-2018.
40. Zhou AL, Egginton S, Brown MD, Hudlicka O. 1998. Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: An ultrastructural study. Anat Rec 252:49-63.